JOSÉ TOMÁS
RAMOS AMADOR
Catedrático de universidad
University of Copenhagen
Copenhague, DinamarcaUniversity of Copenhagen-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2016
2013
2010
-
Is it safe to discontinue primary pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 Cell Count <200 Cells/μL?
Clinical Infectious Diseases, Vol. 51, Núm. 5, pp. 611-619